Efficacy analyses of a randomized phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer refractory to prior S-1 chemotherapy.
Hitoshi Inagaki
No relevant relationships to disclose
Kazuhiro Nishikawa
No relevant relationships to disclose
Kazumasa Fujitani
No relevant relationships to disclose
Naotoshi Sugimoto
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Tadashi Shigematsu
No relevant relationships to disclose
Tohru Ishiguro
No relevant relationships to disclose
Akira Tsuburaya
No relevant relationships to disclose
Masato Nakamura
No relevant relationships to disclose
Atsushi Nashimoto
No relevant relationships to disclose
Takao Yamane
No relevant relationships to disclose
Makoto Yamada
No relevant relationships to disclose
Motohiro Imano
No relevant relationships to disclose
Shohei Iijima
No relevant relationships to disclose
Yoshio Oka
No relevant relationships to disclose
Masato Kataoka
No relevant relationships to disclose
Shuichi Hironaka
Honoraria - Daiichi Sankyo
Hideaki Andoh
No relevant relationships to disclose
Satoshi Morita
Honoraria - Yakult Honsha
Junichi Sakamoto
No relevant relationships to disclose
Toshimasa Tsujinaka
No relevant relationships to disclose